Sonnet BioTherapeutics Holdings, Inc. - FORM S-1 - EX-99.7 - EXHIBIT 99.7 - January 14, 2015

Attached files

file filename
S-1 - S-1 - Sonnet BioTherapeutics Holdings, Inc.v398721_s1.htm
EX-99.4 - EXHIBIT 99.4 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex99-4.htm
EX-99.6 - EXHIBIT 99.6 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex99-6.htm
EX-99.1 - EXHIBIT 99.1 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex99-1.htm
EX-23.1 - EXHIBIT 23.1 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex23-1.htm
EX-99.3 - EXHIBIT 99.3 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex99-3.htm
EX-1.0 - EXHIBIT 1.0 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex1-0.htm
EX-4.10 - EXHIBIT 4.10 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex4-10.htm
EX-4.12 - EXHIBIT 4.12 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex4-12.htm
EX-99.5 - EXHIBIT 99.5 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex99-5.htm
EX-99.2 - EXHIBIT 99.2 - Sonnet BioTherapeutics Holdings, Inc.v398721_ex99-2.htm

 

EXHIBIT 99.7

 

CHANTICLEER HOLDINGS, INC.

 

NOMINEE HOLDER CERTIFICATION

 

The undersigned, a broker, custodian bank, trustee, depositary or other nominee holder of rights (the “Rights”) to purchase shares of common stock (“Common Stock”) of Chanticleer Holdings, Inc. (“Chanticleer”) pursuant to the Rights Offering described and provided for in the Chanticleer prospectus dated [•], 2015 (the “Prospectus”), hereby certifies to Chanticleer, Securities Transfer Corp., as subscription agent for the Rights Offering, and to Okapi Partners, LLC, as information agent for the Rights Offering, that (1) the undersigned has exercised, on behalf of the beneficial owners thereof (which may include the undersigned), the number of Rights specified below pursuant to the basic subscription privilege (as defined in the Prospectus), and on behalf of beneficial owners of Rights who have subscribed for the purchase of additional shares of Common Stock pursuant to the over-subscription privilege (as defined in the Prospectus), listing separately below each such exercised basic subscription privilege and the corresponding over-subscription privilege (without identifying any such beneficial owner), and (2) each such beneficial owner's basic subscription privilege has been exercised in full:

 

Number of Shares of
Common Stock

Owned on the Record
Date

Rights Exercised Pursuant
to Basic

Subscription Privilege

Number of Shares
Subscribed

For Pursuant to

Over-Subscription
Privilege

       
1.      
       
2.      
       
3.      
       
4.      
       
5.      
       
6.      
       
7.      
       
8.      
       
9.      

 

 
 

 

Provide the following information if applicable:

 

Depository Trust Company (“DTC”)

 

Participant Number

 

[PARTICIPANT]

 

By:    
Name:
Title:
DTC Basic Subscription Confirmation Number(s)

 

 

 

Sonnet BioTherapeutics Holdings, Inc. Reports